Total Holdings
59
Portfolio diversification across 59 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Johnson & Johnson | Stock | 24.24% |
| 2 | ![]() | Eli Lilly and Company | Stock | 23.56% |
| 3 | ![]() | Merck & Co., Inc. | Stock | 5.17% |
| 4 | ![]() | Bristol-Myers Squibb Company | Stock | 4.89% |
| 5 | ![]() | Zoetis Inc | Stock | 4.82% |
| 6 | ![]() | Pfizer Inc | Stock | 4.34% |
| 7 | ![]() | Royalty Pharma plc | Stock | 4.31% |
| 8 | ![]() | Viatris Inc. | Stock | 4.29% |
| 9 | ![]() | Elanco Animal Health Incorporated | Stock | 3.21% |
| 10 | ![]() | Jazz Pharmaceuticals plc | Stock | 2.76% |
| 11 | ![]() | Axsome Therapeutics, Inc. | Stock | 1.99% |
| 12 | ![]() | Indivior PLC Ordinary Shares | Stock | 1.23% |
| 13 | ![]() | Crinetics Pharmaceuticals, Inc. | Stock | 1.19% |
| 14 | ![]() | Ligand Pharmaceuticals Incorporated | Stock | 1.05% |
| 15 | ![]() | Corcept Therapeutics Incorporated | Stock | 0.93% |
| 16 | ![]() | Terns Pharmaceuticals Inc | Stock | 0.90% |
| 17 | ![]() | Tarsus Pharmaceuticals Inc | Stock | 0.85% |
| 18 | ![]() | Prestige Consumer Healthcare Inc. | Stock | 0.82% |
| 19 | ![]() | Supernus Pharmaceuticals, Inc | Stock | 0.77% |
| 20 | ![]() | Liquidia Corporation | Stock | 0.74% |
| 21 | ![]() | Amneal Pharmaceuticals, Inc. | Stock | 0.65% |
| 22 | ![]() | Wave Life Sciences Ltd | Stock | 0.59% |
| 23 | ![]() | Avadel Pharmaceuticals plc | Stock | 0.57% |
| 24 | ![]() | Organon & Co. | Stock | 0.57% |
| 25 | ![]() | Nuvation Bio Inc | Stock | 0.55% |
| 26 | ![]() | Perrigo Company plc | Stock | 0.55% |
| 27 | ![]() | Ocular Therapeutix Inc | Stock | 0.52% |
| 28 | ![]() | Edgewise Therapeutics, Inc. | Stock | 0.52% |
| 29 | ![]() | Harrow Health Inc | Stock | 0.48% |
| 30 | ![]() | Harmony Biosciences Holdings Inc | Stock | 0.40% |
| 31 | ![]() | Collegium Pharmaceutical Inc | Stock | 0.40% |
| 32 | ![]() | ANI Pharmaceuticals, Inc | Stock | 0.38% |
| 33 | ![]() | Innoviva, Inc | Stock | 0.37% |
| 34 | ![]() | Mind Medicine (MindMed) Inc | Stock | 0.36% |
| 35 | ![]() | Eyepoint Pharmaceuticals Inc | Stock | 0.36% |
| 36 | ![]() | Xeris Pharmaceuticals Inc | Stock | 0.31% |
| 37 | ![]() | Trevi Therapeutics Inc | Stock | 0.31% |
| 38 | ![]() | Pacira BioSciences, Inc | Stock | 0.30% |
| 39 | ![]() | Amphastar Pharmaceuticals, Inc | Stock | 0.27% |
| 40 | ![]() | Omeros Corporation | Stock | 0.26% |
| 41 | ![]() | Amylyx Pharmaceuticals Inc. Common Stock | Stock | 0.26% |
| 42 | ![]() | Nektar Therapeutics | Stock | 0.24% |
| 43 | ![]() | CorMedix Inc | Stock | 0.22% |
| 44 | ![]() | Maze Therapeutics, Inc. Common Stock | Stock | 0.22% |
| 45 | ![]() | Phibro Animal Health Corporation | Stock | 0.22% |
| 46 | ![]() | Rapport Therapeutics, Inc. Common Stock | Stock | 0.21% |
| 47 | ![]() | Arvinas, Inc | Stock | 0.21% |
| 48 | ![]() | Phathom Pharmaceuticals, Inc | Stock | 0.20% |
| 49 | ![]() | MBX | Stock | 0.20% |
| 50 | ![]() | Theravance Biopharma Inc | Stock | 0.18% |